AIM2 and hydrops fetalis: Administration of probenecid, clinically used as a uricosuric drug, which blocks pannexin-1 channels, significantly reduced AIM2 inflammasome activation in vitro, reduced pressure overload-induced mortality, and restored indices of disease severity in vivo, showing that AIM2 inflammasome activation participates in chronic inflammation in HF (66).